BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20455498)

  • 1. Biological horizons for targeting brain malignancy.
    Hughes SA; Achanta P; Ho AL; Duenas VJ; QuiƱones-Hinojosa A
    Adv Exp Med Biol; 2010; 671():93-104. PubMed ID: 20455498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel treatment strategies for malignant gliomas using neural stem cells.
    Oh MC; Lim DA
    Neurotherapeutics; 2009 Jul; 6(3):458-64. PubMed ID: 19560736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
    Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
    Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliomagenesis and the use of neural stem cells in brain tumor treatment.
    Achanta P; Sedora Roman NI; QuiƱones-Hinojosa A
    Anticancer Agents Med Chem; 2010 Feb; 10(2):121-30. PubMed ID: 20184546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.
    Zhang Q; Xiang W; Yi DY; Xue BZ; Wen WW; Abdelmaksoud A; Xiong NX; Jiang XB; Zhao HY; Fu P
    Stem Cell Res Ther; 2018 Aug; 9(1):228. PubMed ID: 30143053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future strategies for treatment of glioma.
    Bush NA; Chang SM; Berger MS
    Neurosurg Rev; 2017 Jan; 40(1):1-14. PubMed ID: 27085859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma.
    Morokoff A; Ng W; Gogos A; Kaye AH
    J Clin Neurosci; 2015 Aug; 22(8):1219-26. PubMed ID: 25957782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell-based therapies for tumors in the brain: are we there yet?
    Shah K
    Neuro Oncol; 2016 Aug; 18(8):1066-78. PubMed ID: 27282399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
    Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
    Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioma stem cell research for the development of immunotherapy.
    Xu Q; Yuan X; Yu JS
    Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duality of epidermal growth factor receptor (EGFR) signaling and neural stem cell phenotype: cell enhancer or cell transformer?
    Ayuso-Sacido A; Graham C; Greenfield JP; Boockvar JA
    Curr Stem Cell Res Ther; 2006 Sep; 1(3):387-94. PubMed ID: 18220882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology and immunotherapeutic targeting of glioma stem cells.
    Madany M; Thomas TM; Edwards L; Yu JS
    Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.
    Young JS; Morshed RA; Kim JW; Balyasnikova IV; Ahmed AU; Lesniak MS
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1733-46. PubMed ID: 25005767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cells as vehicles for the treatment of brain cancer.
    Mapara KY; Stevenson CB; Thompson RC; Ehtesham M
    Neurosurg Clin N Am; 2007 Jan; 18(1):71-80, ix. PubMed ID: 17244555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma stem cell signaling: therapeutic opportunities and challenges.
    Dietrich J; Diamond EL; Kesari S
    Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy.
    Dunn IF; Black PM
    Neurosurgery; 2003 Jun; 52(6):1411-22; discussion 1422-4. PubMed ID: 12762886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell-based therapy for malignant glioma.
    Bexell D; Svensson A; Bengzon J
    Cancer Treat Rev; 2013 Jun; 39(4):358-65. PubMed ID: 22795538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.